Compare Crispr Therapeutics AG (CRSP) vs Logitech International SA (LOGI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crispr Therapeutics AG vs Logitech International SA — how do they compare? Crispr Therapeutics AG trades at $50.9 (market cap $4.88B), while Logitech International SA trades at $101.34 (market cap $14.46B). The key difference: Logitech International SA is far larger — about 3× Crispr Therapeutics AG's market cap, and Logitech International SA pays a 1.63% dividend while Crispr Therapeutics AG pays none. Which is the better fit depends on your goals — on Pluang, investors hold Crispr Therapeutics AG for 77 Days and Logitech International SA for 92 Days on average.
| CRSP | LOGI | |
|---|---|---|
Market Cap | $4.88B | $14.46B |
Volume | 2,861,747 | 349,547 |
Sector | Health | Technology |
52-Week High | $74.92 | $126.69 |
52-Week Low | $44.34 | $85.84 |
Typical Hold Time | 77 Days | 92 Days |
Enterprise Value | $3.30B | $12.79B |
Dividend Yield | — | 1.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRISPR Therapeutics (CRSP) trades at $52.35, down 3.06% on the day, with a bearish technical signal and negative profitability metrics. The company reported no revenue in 2025 with a net loss of $581.60M, though recent earnings beat expectations in Q2 2026. Analyst sentiment remains positive with a $67.83 price target and 57.9% buy ratings, supported by upcoming clinical data catalysts for its gene-editing therapies.
The stock faces significant fundamental challenges with negative margins and cash burn, but strong analyst support and pipeline progress offer long-term potential. Key risks include clinical trial outcomes and commercialization execution, while institutional interest and positive media coverage provide near-term catalysts for investor consideration.
Logitech (LOGI) trades at $102.18, down slightly (-0.22%) on the day, with a bullish technical signal from moving averages. The company demonstrates strong profitability with a 16.28% net income margin and 35.29% ROE, supported by recent earnings beats. Recent news highlights product launches like the Zone Vibe Pro headset and a partnership with SEGA for Crazy Taxi: World Tour, indicating active business development.
The outlook is cautiously optimistic, with a consensus price target of $107 offering potential upside. Key opportunities include sustained earnings growth and new product cycles, while risks involve competitive pressures in the peripheral market and potential supply chain disruptions, as noted by the CEO addressing chip shortages (WSJ, 2026-09-30).
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crispr Therapeutics AG
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →About Logitech International SA
Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →
